ARS Pharmaceuticals, (id:6523 SPRY)
14.00 USD
Opening hours: 09:30 - 16:00 (Eastern Standard Time: 11/23/2024 7:46:09 PM)
Exchange closed, opens in 1 day 13 hours
4.95 USD (4.95%)
0.39 USD (0.39%)
-8.26 USD (-8.26%)
53.85 USD (53.85%)
191.06 USD (191.06%)
253.54 USD (253.54%)
About ARS Pharmaceuticals,
Market Capitalization 1.36B
ARS Pharmaceuticals, Inc., a biopharmaceutical company, develops treatments for severe allergic reactions. The company is developing neffy, a needle-free and low-dose intranasal epinephrine nasal spray for the emergency treatment of Type I allergic reactions, including anaphylaxis. It serves healthcare professionals, patients, and caregivers. ARS Pharmaceuticals, Inc. was founded in 2015 and is headquartered in San Diego, California.
| Headquarters (address) |
11682 El Camino Real San Diego 92130 CA United States |
| Phone | 858 771 9307 |
| Website | https://ars-pharma.com |
| Employees | 23 |
| Sector | Healthcare |
| Industry | Biotechnology |
| Ticker | SPRY |
| Exchange | NASDAQ Stock Exchange |
| Currency | USD |
| 52 week range | 4.65 - 18.51 |
| Market Capitalization | 1.36B |
| P/E trailing | -24.56 |
| P/E forward | -18.42 |
| Price/Sale | 529.83 |
| Price/Book | 6.76 |
| Beta | 0.998 |
| EPS | -0.500 |
| EPS United States (ID:6, base:3403) | 24.22 |